Sake J. de Vlas - Concepedia

Author

Sake J. de Vlas

Also Known As

De Vlas, Sake J., S De Vlas, S J de Vlas, S de Vlas, S. J. DE VLAS, S. J. De Vlas, S. J. de Vlas, S.J. DE VLAS, S.J. De Vlas, S.J. de VLAS

344

Publications

14.6K

Citations

H-Index

161

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam Institute of Microbiology London School of Hygiene & Tropical Medicine Instituut voor Tropische Geneeskunde

About

Sake J. de Vlas is an author at Erasmus MC specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	46	3.4K
2	Public Health	24	38	2.5K
3	Engineering	4	4	162
4	Business	1	1	47
5	Management	1	1	19

Sake J. de Vlas

206

Publications

11.9K

Citations

H-Index

Page 1

	Year	Citations
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa Marieke J. van der Werf, Sake J. de Vlas, Simon Brooker, Acta Tropica Parasitic DiseaseEpidemiologyClinical MorbidityGlobal HealthPathogenesis	2003	948
Underestimation of Schistosoma mansoni prevalences Sake J. de Vlas, B. Gryseels Parasitology Today Parasitic DiseaseMalariaPathologySchistosomiasisScleroderma	1992	269
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models Jeffrey W. Eaton, Nicolas A. Menzies, John Stover, The Lancet Global Health	2013	244
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis Wilma A. Stolk, Martin Walker, Luc E. Coffeng, Parasites & Vectors	2015	236
Are poor responses to praziquantel for the treatment of <i>Schistosoma mansoni</i> infections in Senegal due to resistance? An overview of the evidence B. Gryseels, Amadou Ibrahima Mbaye, Sake J. de Vlas, Tropical Medicine & International Health	2001	222
Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission André Lin Ouédraogo, Teun Bousema, Petra Schneider, PLoS ONE	2009	213
Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A Michele Spring, James F. Cummings, Christian F. Ockenhouse, PLoS ONE	2009	207
Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications Tarekegn A. Abeku, G.J. van Oortmarssen, Gerard Borsboom, Acta Tropica Temporal VariationsGlobal HealthMalariaEnvironmental HealthVector-parasite Relationship	2003	197
Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal Martin Walker, Wilma A. Stolk, Matthew A. Dixon, Epidemics	2017	184
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa Jan A. C. Hontelez, Sake J. de Vlas, Rob Baltussen, AIDS	2012	174

Page 1